Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare Announces Upcoming Launch of MedWise™ 2.0
“The launch of MedWise™ 2.0 represents an important step in bridging the gap between pharmacists and prescribers to advance the safety of patients’ medication regimens, improve outcomes and reduce costs associated with preventable adverse drug events,” said TRHC Chairman and CEO,
MedWise™ 2.0 will run on an eHealth Medication Risk Mitigation platform that will utilize industry recognized standards for connectivity, compatibility and coordination to improve workflows, patient care and safety. MedWise™ 2.0 will employ the
Specifically, MedWise™ will offer Medication Risk Mitigation technology through SMART on FHIR to enable providers’ access to TRHC’s technology directly from their EHR system. The new SMART on FHIR integration will allow pharmacists and care providers to receive deeper clinical insights, provide better continuity of care and ensure greater patient safety.
CDS Hooks specifications available in MedWise™ 2.0 will alert care providers and care coordinators to their individual patients' Medication Risk Score™ along with the availability of a Medication Safety Review (MSR) for their patients. CDS Hooks will also help ensure that care providers can review recommendations before meeting with a patient, leading to improved adoption of MSR recommendations.
MedWise™ 2.0 is based on TRHC’s proprietary technology for predicting safety risk and ADEs associated with polypharmacy. MedWise™ 2.0 translates the pharmacokinetics, pharmacodynamics, and pharmacogenomics associated with a patient’s medication regimen to formulate meaningful and actionable views of each risks. The technology empowers prescribers to take a more personalized approach to medication management, including medication selection, dosage levels, time-of-day administration and reduction of the total number of medications by eliminating unnecessary prescriptions.
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; acceptance of our products, including MedWise™ 2.0; and the other risk factors set forth from time to time in our filings with the
T: (415) 547-7099
Bob East or Asher Dewhurst
T: (443) 213-0500
Source: Tabula Rasa HealthCare, Inc.